An underground market for unapproved slimming drugs is being driven by social media fitness personalities and vendors on messaging platforms, based on recent findings.
Investigational Treatment Gaining Popularity Via Social Media
The experimental drug, which is still in research studies, is being advertised by social media influencers for its supposed weight-reducing properties. Viewers are encouraged to contact these accounts directly for source information, while also obtaining promotional offers.
Active Commerce on Social Networks
Separately, a flourishing market exists on messaging services, where groups with thousands of participants share comparison photos, administration instructions and claims of next-day British shipping. Sellers market the substance there before redirecting customers to WhatsApp for transactions.
Learning About The Experimental Drug
This medication is an investigational injection developed by American pharmaceutical company Eli Lilly. The treatment targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies indicate it could help patients lose up to a quarter of their body weight. Nicknamed the “triple G”, the drug is being hailed online as the next Ozempic.
Healthcare Professionals Voice Concerns
Nevertheless, doctors and pharmacists have cautions that the sale of what is still an unlicensed drug in the UK is worrisome and could lead to users administering products of uncertain source.
Several experts stated the popularity for the experimental drug could be connected to the rising cost of approved slimming products such as Mounjaro.
Regulatory Status and Implementation
Marketing retatrutide on TikTok or messaging apps is prohibited in the UK, as it is an unlicensed medication that must not be promoted or supplied for human use under the British medical regulations.
Several content creators try to sidestep the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled drug, but promotion and supply can still breach pharmaceutical, advertising, and consumer laws, risking penalties, legal action or prison.
Platform Reaction and Material Elimination
Based on TikTok, the platform has taken down problematic content and banned associated hashtags and search suggestions. The company stated it was committed to keeping the platform safe and allocating resources in strengthening enforcement strategies.
Digital Marketplace Activities
Research also discovered groups with up to 9,000 participants selling the experimental drug using Telegram's built-in discovery tool, which functions like a public directory. Entering “retatrutide” immediately displays channels with thousands of users, populated with images of weight loss, positive testimonials and detailed instructions for preparing or administering at residence.
Within moments of joining one group, a seller posted WhatsApp details, where most transactions occur. The vendor sent an instruction manual and promised delivery within two days. When questioned whether the substance was authentic, one vendor said: “You can’t be sure.” Another provided a photo of a alleged testing documentation. None asked about weight, medical conditions or previous experience.
Item Information and Pricing
Within these groups, posts display dark colored parcels with Royal Mail labels, stating to contain fresh supplies. One message read: “It took eight of us to load them this morning.”
Customers can choose between dry substance containers, prepared at residence with sterile water, or pre-filled pens usually sold at 160 pounds for 20mg. When asked how much time a pen should be used, vendors give conflicting answers ranging from a several days to “depends on your body”.
Platform Moderation and Security Measures
A spokesperson for Telegram said it actively monitored dangerous material on its platform including material that encouraged the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.
Healthcare Expert Cautions
“People are injecting substances they can’t verify. Although the research behind this drug is sound, these online versions may not contain what they advertise,” said Jason Murphy, the director of pharmacy at a pharmacy service.
Dr Crystal Wyllie of Asda Online Doctor linked the increase in interest to recent price rises for authorized slimming medications such as Mounjaro. “With prices increasing, individuals are turning to online platforms. But fake treatments are extremely dangerous. You can’t be certain what’s contained or whether the environment they were made in was clean,” she said.
Her staff has already seen patients injured by personal administration from unconfirmed sources. “We recognize the disappointment, but buying from messaging apps or WhatsApp is gambling with your health,” stated the doctor. “These materials could be contaminated or improperly measured.”
Producer Statement
A representative from Eli Lilly said retatrutide was in third stage clinical trials and had not been evaluated or approved by any government authority globally. “Therefore at this point no one can market [it] for human use,” they said, noting that any product “misleadingly claiming itself as a Lilly investigational substance not yet authorized … may expose users to possibly significant health risks”.
